Donor Warm Ischemia Time in DCD Liver Transplantation-Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
01 06 2021
Historique:
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 27 7 2021
Statut: ppublish

Résumé

Donation after circulatory death (DCD) grafts are commonly used in liver transplantation. Attributable to the additional ischemic event during the donor warm ischemia time (DWIT), DCD grafts carry an increased risk for severe ischemia/reperfusion injury and postoperative complications, such as ischemic cholangiopathy. The actual ischemia during DWIT depends on the course of vital parameters after withdrawal of life support and varies widely between donors. The ischemic period (functional DWIT) starts when either Spo2 or blood pressure drop below a certain point and lasts until the start of cold perfusion during organ retrieval. Over the years, multiple definitions and thresholds of functional DWIT duration have been used. The International Liver Transplantation Society organized a Consensus Conference on DCD, Liver Preservation, and Machine Perfusion on January 31, 2020 in Venice, Italy. The aim of this conference was to reach consensus about various aspects of DCD liver transplantation in context of currently available evidence. Here we present the recommendations with regards to the definitions used for DWIT and functional DWIT, the importance of vital parameters after withdrawal of life support, and acceptable thresholds of duration of functional DWIT to proceed with liver transplantation.

Identifiants

pubmed: 34048418
doi: 10.1097/TP.0000000000003819
pii: 00007890-202106000-00006
doi:

Types de publication

Consensus Development Conference Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1156-1164

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Beecher HK. A definition of irreversible coma: report of the ad hoc committee of the Harvard Medical School to examine the definition of brain death. JAMA. 1968;205:337340.
Müllhaupt B, Dimitroulis D, Gerlach JT, et al. Hot topics in liver transplantation: organ allocation extended criteria donor living donor liver transplantation. J Hepatol. 2008;48(Suppl 1):S58–S67.
Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146:543552–552. Discussion553.
Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2006;6:791–796.
de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9:773–781.
Taner CB, Bulatao IG, Perry DK, et al. Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int. 2012;25:838–846.
Monbaliu D, Crabbé T, Roskams T, et al. Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation. 2005;79:1226–1230.
DeOliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg. 2011;254:716–722.
Seal JB, Bohorquez H, Reichman T, et al. Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors. Liver Transplant. 2015;21:321–328.
Croome KP, Lee DD, Perry DK, et al. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017;23:342–351.
Laing RW, Scalera I, Isaac J, et al. Liver transplantation using grafts from donors after circulatory death: a propensity score-matched study from a single center. Am J Transplant. 2016;16:1795–1804.
Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant. 2018;18:172–253.
Davila D, Ciria R, Jassem W, et al. Prediction models of donor arrest and graft utilization in liver transplantation from maastricht-3 donors after circulatory death. Am J Transplant. 2012;12:3414–3424.
Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926.
Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29:749–759.
Kalisvaart M, de Haan JE, Polak WG, et al. Onset of donor warm ischemia time in donation after circulatory death liver transplantation: hypotension or hypoxia? Liver Transpl. 2018;24:1001–1010.
Firl DJ, Hashimoto K, O’Rourke C, et al. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016;22:1469–1481.
Ho KJ, Owens CD, Johnson SR, et al. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation. 2008;85:1588–1594.
Abt PL, Praestgaard J, West S, et al. Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation. Liver Transpl. 2014;20:165–172.
Allen MB, Billig E, Reese PP, et al. Donor hemodynamics as a predictor of outcomes after kidney transplantation from donors after cardiac death. Am J Transplant. 2016;16:181–193.
Hong JC, Yersiz H, Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146:1017–1023.
Ruiz P, Gastaca M, Bustamante FJ, et al. Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death: a single-center experience. Transplantation. 2019;103:938–943.
Farid SG, Attia MS, Vijayanand D, et al. Impact of donor hepatectomy time during organ procurement in donation after circulatory death liver transplantation: the United Kingdom experience. Transplantation. 2019;103:e79–e88.
Khorsandi S, Giorgakis E, Vilca-Melendez H, et al. Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant. 2017;7:203–212.
Jochmans I, Fieuws S, Tieken I, et al. The impact of hepatectomy time of the liver graft on post-transplant outcome: a Eurotransplant Cohort Study. Ann Surg. 2017;269:712–717.
Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 2006;82:1683–1688.
Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl. 2008;14:604–610.
Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10:2512–2519.
Doyle MB, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015;221:142–152.
Chirichella TJ, Dunham CM, Zimmerman MA, et al. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016;22:3392–3403.
Kubal C, Mangus R, Fridell J, et al. Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation. Transplantation. 2016;100:1699–1704.
Coffey JC, Wanis KN, Monbaliu D, et al. The influence of functional warm ischemia time on DCD liver transplant recipients’ outcomes. Clin Transplant. 2017;31:e13068–e13070.
Schlegel A, Kalisvaart M, Scalera I, et al. The UK DCD Risk Score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018;68:456–464.
Rhee JY, Alroy J, Freeman RB. Characterization of the withdrawal phase in a porcine donation after the cardiac death model. Am J Transplant. 2011;11:1169–1175.
Iyer A, Chew HC, Gao L, et al. Pathophysiological trends during withdrawal of life support: implications for organ donation after circulatory death. Transplantation. 2016;100:2621–2629.
Henrion J. Hypoxic hepatitis. Liver Int. 2012;32:1039–1052.
Zhang J, Hu W, Xing W, et al. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol. 2011;179:2876–2884.
Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011;253:259–264.
Taner CB, Bulatao IG, Willingham DL, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012;18:100–111.
Wilson S, Cecins N, Jenkins S, et al. Comparing finger and forehead sensors to measure oxygen saturation in people with chronic obstructive pulmonary disease. Respirology. 2013;18:1143–1147.
Nuhr M, Hoerauf K, Joldzo A, et al. Forehead SpO 2 monitoring compared to finger SpO 2 recording in emergency transport. Anaesthesia. 2004;59:390–393.
Van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in the intensive care unit. Intensive Care Med. 2001;27:1606–1613.
Carter BG, Carlin JB, Tibballs J, et al. Accuracy of two pulse oximeters at low arterial hemoglobin-oxygen saturation. Crit Care Med. 1998;26:1128–1133.
Sinex JE. Pulse Oximetry: Principles and Limitations. Am J Emerg Med. 1999;17:59–67.
Reich DJ, Mulligan DC, Abt PL, et al.; ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009;9:2004–2011.
Intensive Care Society; NHS Blood and Transplant; British Transplantation Society. Organ Donation after Circulatory Death. 2010. Report of a Consensus Meeting; doi:10.1007/s13398-014-0173-7.2
Eurotransplant. Eurotransplant Manual - Chapter 9 The Donor. 2016.
Abradelo de Usera M, Blasi Ibáñez A, Fundora Suárez Y, Fondevila Campo C, Gómez Gutiérrez M, Sánchez Turrión V. Protocolo Nacional de Donación y Trasplante Hepático En Donación En Asistolía Controlada. 2015.
Dünser MW, Takala J, Ulmer H, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35:1225–1233.
Kato R, Pinsky MR. Personalizing blood pressure management in septic shock. Ann Intensive Care. 2015;5:41.
Cao Y, Shahrestani S, Chew HC, et al. Donation after circulatory death for liver transplantation: a meta-analysis on the location of life support withdrawal affecting outcomes. Transplantation. 2016;100:1513–1524.
Hessheimer AJ, Polak W, Antoine C, et al. Regulations and procurement surgery in DCD liver transplantation: expert consensus guidance from the International Liver Transplantation Society. Transplantation. 2021;105:945–951.
Jochmans I, Fieuws S, Tieken I, et al. The impact of implantation time during liver transplantation on outcome: a Eurotransplant Cohort Study. Transplant Direct. 2018;4:e356.

Auteurs

Marit Kalisvaart (M)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Kristopher P Croome (KP)

Department of Transplant, Mayo Clinic Florida, Jacksonville, FL.

Roberto Hernandez-Alejandro (R)

Division of Transplantation, University of Rochester, Rochester, NJ.

Jacques Pirenne (J)

Department of Abdominal Transplant Surgery, University Hospital Leuven, Leuven, Belgium.

Miriam Cortés-Cerisuelo (M)

Department of Liver Transplantation, Institute of Liver Studies, King's College Hospital NHS Trust, London, United Kingdom.

Eduardo Miñambres (E)

Transplant Coordination Unit and Service of Intensive Care, University Hospital Marqués de Valdecilla-IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.

Peter L Abt (PL)

Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH